Viewing Study NCT00352066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-01-18 @ 8:52 PM
Study NCT ID: NCT00352066
Status: COMPLETED
Last Update Posted: 2011-06-23
First Post: 2006-07-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together
Sponsor: Avexa
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human Immunodeficiency Virus View
None anti-retroviral therapy View
None nucleoside analogue View
None reverse transcriptase View
None apricitabine View
None tipranavir View
None bioequivalence View
None drug-drug interaction View
None pharmacokinetics View